Answers are grounded in this paper and cite their sources.
An implanted antenna can support cancer surveillance when a disease-related change produces a reproducible measurement that can be distinguished from relevant benign changes and interpreted within a defined clinical pathway. This critical review connects cancer biomarkers, local physiological changes, biosensor mechanisms, and in-body RF interfaces across major tumour sites, with particular attention to oral, head and neck, and lung cancer. Three approaches are distinguished: antennas that sense tissue dielectric properties, chemically functionalized antenna immunosensors, and separate cancer sensors coupled to implanted radio telemetry. The unresolved problem is durable, site- and endpoint-specific surveillance under realistic sampling, inflammatory, biointerface, and wireless constraints. Comparative evidence tables identify measured specimens, demonstrated endpoints, candidate sensor–antenna combinations, and decisive missing experiments. A compact quantitative framework links target access, binding, RF observability, confounder control, read availability, and false-alert burden. A gated development workflow, illustrated using a published CEA antenna, converts these constraints into testable research requirements. The outcome is a research roadmap for clinically interpretable local warnings.
No takes yet. Share an insight, caveat, or question.
Sumer Singh Singhwal (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: